Follow
Patricia R. Freeman, PhD, RPh, FAPhA, FNAP
Patricia R. Freeman, PhD, RPh, FAPhA, FNAP
Earl Platt Slone Endowed Professor, Pharmacy Practice and Science, University of Kentucky
Verified email at uky.edu
Title
Cited by
Cited by
Year
Eliciting willingness to pay without bias: evidence from a field experiment
K Blumenschein, GC Blomquist, M Johannesson, N Horn, P Freeman
The Economic Journal 118 (525), 114-137, 2008
4812008
Hypothetical versus real willingness to pay in the health care sector: results from a field experiment
K Blumenschein, M Johannesson, K Yokoyama, P Freeman
Value in Health 4 (2), 79-79, 2001
3032001
Assessment of the relationship between measures of disease severity, quality of life, and willingness to pay in asthma
AJ Zillich, K Blumenschein, M Johannesson, P Freeman
Pharmacoeconomics 20, 257-265, 2002
912002
The changing landscape of naloxone availability in the United States, 2011–2017
PR Freeman, ER Hankosky, MR Lofwall, JC Talbert
Drug and alcohol dependence 191, 361-364, 2018
902018
Association of naloxone coprescription laws with naloxone prescription dispensing in the United States
M Sohn, JC Talbert, Z Huang, MR Lofwall, PR Freeman
JAMA network open 2 (6), e196215-e196215, 2019
812019
Pharmacists’ role in opioid overdose: Kentucky pharmacists’ willingness to participate in naloxone dispensing
PR Freeman, A Goodin, SZ Troske, A Strahl, A Fallin, TC Green
Journal of the American Pharmacists Association 57 (2), S28-S33, 2017
812017
Buprenorphine dispensing in an epicenter of the US opioid epidemic: a case study of the rural risk environment in Appalachian Kentucky
HLF Cooper, DH Cloud, PR Freeman, M Fadanelli, T Green, C Van Meter, ...
International Journal of Drug Policy 85, 102701, 2020
802020
The HEALing (Helping to End Addiction Long-term SM) Communities Study: Protocol for a cluster randomized trial at the community level to reduce opioid overdose deaths through …
SL Walsh, N El-Bassel, RD Jackson, JH Samet, M Aggarwal, AP Aldridge, ...
Drug and alcohol dependence 217, 108335, 2020
682020
The opioid-overdose reduction continuum of care approach (ORCCA): evidence-based practices in the HEALing communities study
T Winhusen, A Walley, LC Fanucchi, T Hunt, M Lyons, M Lofwall, ...
Drug and alcohol dependence 217, 108325, 2020
642020
Features of prescription drug monitoring programs associated with reduced rates of prescription opioid-related poisonings
NJ Pauly, S Slavova, C Delcher, PR Freeman, J Talbert
Drug and alcohol dependence 184, 26-32, 2018
642018
Implementation of personalized medicine services in community pharmacies: perceptions of independent community pharmacists
KM Alexander, HS Divine, CR Hanna, Y Gokun, PR Freeman
Journal of the American Pharmacists Association 54 (5), 510-517, 2014
642014
Trends and patterns of opioid analgesic prescribing: Regional and rural‐urban variations in Kentucky from 2012 to 2015
H Luu, S Slavova, PR Freeman, M Lofwall, S Browning, H Bush
The Journal of Rural Health 35 (1), 97-107, 2019
562019
Utilization of prescription drug monitoring programs for prescribing and dispensing decisions: Results from a multi-site qualitative study
PR Freeman, GM Curran, KL Drummond, BC Martin, BS Teeter, K Bradley, ...
Research in Social and Administrative Pharmacy 15 (6), 754-760, 2019
532019
When prescribing isn't enough-pharmacy-level barriers to buprenorphine access
HLF Cooper, DH Cloud, AM Young, PR Freeman
The New England journal of medicine 383 (8), 703-705, 2020
492020
Trends in gabapentin prescribing in a commercially insured US adult population, 2009-2016
NJ Pauly, C Delcher, S Slavova, E Lindahl, J Talbert, PR Freeman
Journal of managed care & specialty pharmacy 26 (3), 246-252, 2020
482020
Community engagement to implement evidence-based practices in the HEALing communities study
LS Martinez, BD Rapkin, A Young, B Freisthler, LS Glasgow, T Hunt, ...
Drug and alcohol dependence 217, 108326, 2020
472020
Angiotensin II and monocrotaline-induced pulmonary hypertension: effect of losartan (DuP 753), a nonpeptide angiotensin type 1 receptor antagonist.
LA Cassis, PE Rippetoe, EE Soltis, DJ Painter, R Fitz, MN Gillespie
Journal of Pharmacology and Experimental Therapeutics 262 (3), 1168-1172, 1992
461992
Consumer/patient encounters with prescription drug monitoring programs: evidence from a Medicaid population
A Goodin, K Blumenschein, PR Freeman, J Talbert
Pain physician 15 (3 Suppl), ES169, 2012
412012
Polyamines and epidermal growth factor in monocrotaline-induced pulmonary hypertension.
MN Gillespie, PE Rippetoe, CA Haven, RT Shiao, U Orlinska, BE Maley, ...
American Journal of Respiratory and Critical Care Medicine 140 (5), 1463-1466, 1989
411989
Smooth muscle actin and myosin expression in cultured airway smooth muscle cells
JZ Wong, J Woodcock-Mitchell, J Mitchell, P Rippetoe, S White, M Absher, ...
American Journal of Physiology-Lung Cellular and Molecular Physiology 274 (5 …, 1998
391998
The system can't perform the operation now. Try again later.
Articles 1–20